Literature DB >> 21098098

Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR.

Gregory S Walker1, Tim F Ryder, Raman Sharma, Evan B Smith, Amy Freund.   

Abstract

In discovery and development, having a qualified metabolite standard is advantageous. Chemical synthesis of metabolite standards is often difficult and expensive. As an alternative, biological generation and isolation of metabolites in the nanomole range are readily feasible. However, without an accurately defined concentration, these isolates have limited utility as standards. There is a significant history of NMR as both a qualitative and a quantitative technique, and these concepts have been merged recently to provide both structural and quantitative information on biologically generated isolates from drug metabolism studies. Previous methodologies relied on either specialized equipment or the use of an internal standard to the isolate. We have developed a technique in which a mathematically generated signal can be inserted into a spectrum postacquisition and used as a quantitative reference: artificial signal insertion for calculation of concentration observed (aSICCO). This technique has several advantages over previous methodologies. Any region in the analyte spectra, free from interference, can be chosen for the reference signal. In addition, the magnitude of the inserted signal can be modified to appropriately match the intensity of the sample resonances. Because this is postacquisition quantification, no special equipment or pulse sequence is needed. Compared with quantitation via the addition of an internal standard (10 mM maleic acid), the signal insertion method produced similar results. For each method, precision and accuracy were within ± 5%, stability of signal response over 8 days was ± 5%, and the dynamic range was more than 3 orders of magnitude: 10 to 0.01 mM.

Entities:  

Mesh:

Year:  2010        PMID: 21098098     DOI: 10.1124/dmd.110.036343

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides.

Authors:  Brandon T Gufford; Tyler N Graf; Noemi D Paguigan; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2015-08-27       Impact factor: 3.922

2.  Meeting report: metabolites in safety testing (MIST) symposium-safety assessment of human metabolites: what's REALLY necessary to ascertain exposure coverage in safety tests?

Authors:  Hongying Gao; Abigail Jacobs; Ronald E White; Brian P Booth; R Scott Obach
Journal:  AAPS J       Date:  2013-07-03       Impact factor: 4.009

3.  Small molecule quantification by liquid chromatography-mass spectrometry for metabolites of drugs and drug candidates.

Authors:  Upendra P Dahal; Jeffrey P Jones; John A Davis; Dan A Rock
Journal:  Drug Metab Dispos       Date:  2011-09-21       Impact factor: 3.922

Review 4.  Addressing the challenges of low clearance in drug research.

Authors:  Li Di; R Scott Obach
Journal:  AAPS J       Date:  2015-01-08       Impact factor: 4.009

5.  The tandem of full spin analysis and qHNMR for the quality control of botanicals exemplified with Ginkgo biloba.

Authors:  José G Napolitano; Tanja Gödecke; María F Rodríguez-Brasco; Birgit U Jaki; Shao-Nong Chen; David C Lankin; Guido F Pauli
Journal:  J Nat Prod       Date:  2012-02-14       Impact factor: 4.050

Review 6.  Quantitative 1H NMR. Development and potential of an analytical method: an update.

Authors:  Guido F Pauli; Tanja Gödecke; Birgit U Jaki; David C Lankin
Journal:  J Nat Prod       Date:  2012-04-06       Impact factor: 4.050

7.  Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.

Authors:  Caroline A Lee; J P Jones; Jonathan Katayama; Rüdiger Kaspera; Ying Jiang; Sascha Freiwald; Evan Smith; Gregory S Walker; Rheem A Totah
Journal:  Drug Metab Dispos       Date:  2012-02-10       Impact factor: 3.922

8.  Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production.

Authors:  José Pérez-Del Palacio; Caridad Díaz; Noemí Vergara; Francesca Algieri; Alba Rodríguez-Nogales; Nuria de Pedro; M Elena Rodríguez-Cabezas; Olga Genilloud; Julio Gálvez; Francisca Vicente
Journal:  Front Pharmacol       Date:  2017-04-12       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.